{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:04:48Z","timestamp":1778713488751,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.nmd.2004.03.011","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T16:23:03Z","timestamp":1086798183000},"page":"429-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model"],"prefix":"10.1016","volume":"14","author":[{"given":"Markus","family":"Wehner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Rueffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fritjoff","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derk","family":"Olthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2004.03.011_BIB1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D","article-title":"Genetics and pathogenesis of malignant hyperthermia","volume":"23","author":"Jurkatt-Rott","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2004.03.011_BIB2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/343559a0","article-title":"The ryanodine receptor gene: a candidate gene for preposition to malignant hyperthermia","volume":"343","author":"MacLennan","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2004.03.011_BIB3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/343562a0","article-title":"Localization of malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2","volume":"343","author":"McCarthy","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2004.03.011_BIB4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D","article-title":"Ryanodine receptor mutation in malignant hyperthermia and central core disease","volume":"15","author":"McCarthy","year":"2000","journal-title":"Human Mutat"},{"key":"10.1016\/j.nmd.2004.03.011_BIB5","article-title":"Functional defects in six RyR1 mutations associated with malignant hyperthermia and their impact on skeletal E-C coupling","author":"Yang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2004.03.011_BIB6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","article-title":"A protocol for the investigation of Malignant hyperpyrexia (MH) susceptibility","volume":"56","author":"The European Malignant Hyperpyrexia Group","year":"1984","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2004.03.011_BIB7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia","volume":"86","author":"Urwyler","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2004.03.011_BIB8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low-risk subjects","volume":"41","author":"\u00d8rding H. for the European Malignant Hyperthermia Group","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.nmd.2004.03.011_BIB9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00019052-199510000-00013","article-title":"Discordance between phenotype and genotype in malignant hyperthermia","volume":"8","author":"MacLennan","year":"1995","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2004.03.011_BIB10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/bja\/83.6.855","article-title":"Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes","volume":"83","author":"Brinkmeier","year":"1999","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2004.03.011_BIB11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1399-0004.2002.620206.x","article-title":"Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from MHS-individuals carrying the RyR1 Thr2206Met (C6617T) mutation","volume":"62","author":"Wehner","year":"2002","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2004.03.011_BIB12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/bja\/aef237","article-title":"Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human muscle cells","volume":"89","author":"Girard","year":"2002","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2004.03.011_BIB13","first-page":"26332","article-title":"Caffeine and halothane sensitivity of intracellular Ca2+release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and\/or central core disease","volume":"272","author":"Tong","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.nmd.2004.03.011_BIB14","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1172\/JCI993","article-title":"Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals","volume":"101","author":"Censier","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2004.03.011_BIB15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0960-8966(01)00202-4","article-title":"Identification and functional characterization of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families","volume":"11","author":"Sambuughin","year":"2001","journal-title":"Neuromus Disord"},{"key":"10.1016\/j.nmd.2004.03.011_BIB16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0143-4160(03)00072-1","article-title":"The Ile2453Thr mutation in the ryanodine receptor gene 1 is associated with facilitated calcium release from sarcoplasmic reticulum by 4-chloro-m-cresol in human myotubes","volume":"34","author":"Wehner","year":"2003","journal-title":"Cell Calcium"},{"key":"10.1016\/j.nmd.2004.03.011_BIB17","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+indicators with greatly improved fluorescence properties","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2004.03.011_BIB18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0143-4160(97)90099-3","article-title":"Excitation-contraction coupling of cultured human skeletal muscle cells and the relation between basal cytosolic Ca2+ and excitability","volume":"21","author":"Benders","year":"1997","journal-title":"Cell Calcium"},{"key":"10.1016\/j.nmd.2004.03.011_BIB19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/109065703322537214","article-title":"Calcium Release from Sarcoplasmic Reticulum is facilitated in human myotubes derived from carriers of the Ryanodine Receptor Type 1 mutations Ile2182Phe and Gly2375Ala","volume":"7","author":"Wehner","year":"2003","journal-title":"Gen Test"},{"key":"10.1016\/j.nmd.2004.03.011_BIB20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/mus.880080502","article-title":"Intracellular ionized calcium concentration in muscles from humans with malignant hyperthermia","volume":"8","author":"Lopez","year":"1985","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2004.03.011_BIB21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00000542-199205000-00008","article-title":"Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia","volume":"76","author":"Lopez","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2004.03.011_BIB22","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0026-895X(25)13345-2","article-title":"Chlorocresol: An activator of ryanodine receptor-mediated Ca2+release","volume":"44","author":"Zorzato","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.nmd.2004.03.011_BIB23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00000539-200001000-00040","article-title":"A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibility","volume":"90","author":"Baur","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.nmd.2004.03.011_BIB24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1042\/bj3010661","article-title":"Alteration of intracellular Ca2+transients in COS-7 cells transfected with the cDNA encoding skeletal-muscle ryanodine receptor carrying a mutation with malignant hyperthermia","volume":"301","author":"Treves","year":"1994","journal-title":"Biochem J"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896604000987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896604000987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:52:05Z","timestamp":1760773925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896604000987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0960896604000987"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2004.03.011","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2004.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}